Argenx Se (ARGX) Enterprise Value Growth (3y) (2018 - 2025)

Argenx Se (ARGX) Enterprise Value Growth (3y) (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -26.52%
Jun 30, 2025 -791.80%
Dec 31, 2024 -13.08%
Jun 30, 2024 641.28%
Dec 31, 2023 -17.91%
Jun 30, 2023 2.11%
Dec 31, 2022 -14.03%
Jun 30, 2022 -34.77%
Dec 31, 2021 -53.63%
Jun 30, 2021 -89.02%
Dec 31, 2020 -66.06%
Jun 30, 2020 -123.50%
Dec 31, 2019 -141.91%
Dec 31, 2018 -140.38%